Patient indicated for type I atrial flutter ablations with at least 1 documented episode of type I atrial flutter within 6 months (180 days) of enrollment
Patient 18 years and older
You may not be if
Contraindications for MRI procedures
Patients who cannot have anti-arrhythmic drugs (class I or class III) prescribed for the treatment of type I atrial flutter stopped on the day of the procedure
Previous CTI ablation procedures
Myocardial infarction within 60 days of enrollment
Current unstable angina
Cardiac surgery within 90 days of enrollment
Any cerebral ischemic event (including transient ischemic attacks) within 6 months (180 days) of enrollment
Thrombocytosis or thrombocytopenia
Contraindication to anticoagulation therapy
Currently documented intracardiac thrombus or myxoma
Implantation of permanent leads of an implantable device in or through the right atrium within 90 days of enrollment
Prosthetic valve through which the catheter must pass
Interatrial baffle or patch through which the catheter must pass
Moderate or severe tricuspid valve regurgitation or stenosis
Uncompensated congestive heart failure
Active systemic infection
Pregnancy or if subject plans to become pregnant during the trial
Uncontrolled hyperthyroidism
Any other significant uncontrolled or unstable medical condition
Enrollment in any concurrent study without Imricor written approval
Life expectancy of less than or equal to 2 years (730 days) per physician opinion
Clareo Health | Atrial Flutter Ablation in the iCMR
